{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:17:45Z","timestamp":1792466265129,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-025-05669-0","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:05:51Z","timestamp":1761041151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adjunctive terlipressin versus placebo in the treatment of refractory septic shock: a randomized, placebo-controlled trial"],"prefix":"10.1186","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3772-2990","authenticated-orcid":false,"given":"Surat","family":"Tongyoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chawanee","family":"Chayakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thipdhorn","family":"Aritajati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Tanyalakmara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"22","key":"5669_CR1","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMra2403213","volume":"391","author":"NJ Meyer","year":"2024","unstructured":"Meyer NJ, Prescott HC. Sepsis and septic shock. N Engl J Med. 2024;391(22):2133\u201346. https:\/\/doi.org\/10.1056\/NEJMra2403213.","journal-title":"N Engl J Med"},{"issue":"5","key":"5669_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00134-019-05596-z","volume":"45","author":"G Geri","year":"2019","unstructured":"Geri G, Vignon P, Aubry A, Fedou AL, Charron C, Silva S, et al. Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters: a post hoc analysis. Intensive Care Med. 2019;45(5):657\u201367. https:\/\/doi.org\/10.1007\/s00134-019-05596-z.","journal-title":"Intensive Care Med"},{"issue":"11","key":"5669_CR3","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337.","journal-title":"Crit Care Med"},{"issue":"1","key":"5669_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-021-00555-7","volume":"9","author":"M Egi","year":"2021","unstructured":"Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020). J Intensive Care. 2021;9(1):53. https:\/\/doi.org\/10.1186\/s40560-021-00555-7.","journal-title":"J Intensive Care"},{"issue":"6","key":"5669_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/CCM.0000000000003119","volume":"46","author":"MM Levy","year":"2018","unstructured":"Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle update. Crit Care Med. 2018;46(6):997\u20131000. https:\/\/doi.org\/10.1097\/CCM.0000000000003119. PMID: 29767636.","journal-title":"Crit Care Med"},{"issue":"9","key":"5669_CR6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1164\/rccm.201806-1034OC","volume":"199","author":"C Permpikul","year":"2019","unstructured":"Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial. Am J Respir Crit Care Med. 2019;199(9):1097\u2013105. https:\/\/doi.org\/10.1164\/rccm.201806-1034OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"5669_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jcrc.2020.02.014","volume":"57","author":"R Domizi","year":"2020","unstructured":"Domizi R, Calcinaro S, Harris S, Beilstein C, Boerma C, Chiche JD, et al. Relationship between norepinephrine dose, tachycardia and outcome in septic shock: a multicenter evaluation. J Crit Care. 2020;57:185\u201390.","journal-title":"J Crit Care"},{"key":"5669_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13613-017-0261-x","volume":"7","author":"T Auchet","year":"2017","unstructured":"Auchet T, Regnier MA, Girerd N, Levy B. Outcome of patients with septic shock and high-dose vasopressor therapy. Ann Intensive Care. 2017;7:43.","journal-title":"Ann Intensive Care"},{"key":"5669_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-018-0280-1","volume":"6","author":"H Yamamura","year":"2018","unstructured":"Yamamura H, Kawazoe Y, Miyamoto K, Yamamoto T, Ohta Y, Morimoto T. Effect of norepinephrine dosage on mortality in patients with septic shock. J Intensive Care. 2018;6:12.","journal-title":"J Intensive Care"},{"issue":"1","key":"5669_CR10","doi-asserted-by":"publisher","first-page":"e2022886","DOI":"10.31584\/jhsmr.2022886","volume":"41","author":"S Tongyoo","year":"2022","unstructured":"Tongyoo S, Tanyalakmara T, Naorungroj T, Promsin P, Permpikul C. The association of high dose vasopressor and delayed vasopressor titration with 28-day mortality in adult patients with septic shock. J Health Sci Med Res. 2022;41(1):e2022886. https:\/\/doi.org\/10.31584\/jhsmr.2022886.","journal-title":"J Health Sci Med Res"},{"issue":"11","key":"5669_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142605","volume":"10","author":"A Belletti","year":"2015","unstructured":"Belletti A, Musu M, Silvetti S, Saleh O, Pasin L, Monaco F, et al. Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials. PLoS ONE. 2015;10(11):e0142605. https:\/\/doi.org\/10.1371\/journal.pone.0142605.","journal-title":"PLoS ONE"},{"issue":"9","key":"5669_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, Gordon AC, H\u00e9bert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877\u201387. https:\/\/doi.org\/10.1056\/NEJMoa067373.","journal-title":"N Engl J Med"},{"issue":"12","key":"5669_CR13","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1345\/aph.1H373","volume":"40","author":"AB Pesaturo","year":"2006","unstructured":"Pesaturo AB, Jennings HR, Voils SA. Terlipressin: vasopressin analog and novel drug for septic shock. Ann Pharmacother. 2006;40(12):2170\u20137. https:\/\/doi.org\/10.1345\/aph.1H373.","journal-title":"Ann Pharmacother"},{"key":"5669_CR14","doi-asserted-by":"crossref","unstructured":"Aritajati T, Chayakul C, Tongyoo S. Terlipressin 2022 for refractory septic shock: a study protocol of a single center, placebo-controlled double-blind phase III RCT (The TERESEP study). Clin Crit Care [internet]. [cited 2025 May 6];30:2022:e0003. available from: https:\/\/he02.tci-thaijo.org\/index.php\/ccc\/article\/view\/254966.","DOI":"10.54205\/ccc.v30.254966"},{"issue":"11","key":"5669_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","volume":"152","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726\u201332. https:\/\/doi.org\/10.7326\/0003-4819-152-11-201006010-00232.","journal-title":"Ann Intern Med"},{"key":"5669_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"issue":"1","key":"5669_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13613-021-00817-5","volume":"11","author":"JI Alvarado S\u00e1nchez","year":"2021","unstructured":"Alvarado S\u00e1nchez JI, Caicedo Ruiz JD, Diaztagle Fern\u00e1ndez JJ, Amaya Zu\u00f1iga WF, Ospina-Tasc\u00f3n GA, Cruz Mart\u00ednez LE. Predictors of fluid responsiveness in critically ill patients mechanically ventilated at low tidal volumes: systematic review and meta-analysis. Ann Intensive Care. 2021;11(1):28. https:\/\/doi.org\/10.1186\/s13613-021-00817-5.","journal-title":"Ann Intensive Care"},{"key":"5669_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jcrc.2020.11.002","volume":"61","author":"S Goradia","year":"2021","unstructured":"Goradia S, Sardaneh AA, Narayan SW, et al. Vasopressor dose equivalence: a scoping review and suggested formula. J Crit Care. 2021;61:233\u201340. https:\/\/doi.org\/10.1016\/j.jcrc.2020.11.002.","journal-title":"J Crit Care"},{"key":"5669_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jcrc.2018.05.003","volume":"47","author":"JA Russell","year":"2018","unstructured":"Russell JA, Lee T, Singer J, De Backer D, Annane D. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials. J Crit Care. 2018;47:333\u20137. https:\/\/doi.org\/10.1016\/j.jcrc.2018.05.003.","journal-title":"J Crit Care"},{"key":"5669_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017;377:419\u201330.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"5669_CR21","first-page":"S238","volume":"96","author":"S Tongyoo","year":"2013","unstructured":"Tongyoo S, Permpikul C, Haemin R, Epichath N. Predicting factors, incidence and prognosis of cardiac arrhythmia in medical, non-acute coronary syndrome, critically ill patients. J Med Assoc Thai. 2013;96(Suppl 2):S238-45.","journal-title":"J Med Assoc Thai"},{"key":"5669_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/cc7990","volume":"13","author":"A Morelli","year":"2009","unstructured":"Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care. 2009;13:R130.","journal-title":"Crit Care"},{"key":"5669_CR23","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1007\/s00134-018-5267-9","volume":"44","author":"ZM Liu","year":"2018","unstructured":"Liu ZM, Chen J, Kou Q, Lin Q, Huang X, Tang Z, et al. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med. 2018;44:1816\u201325.","journal-title":"Intensive Care Med"},{"issue":"6","key":"5669_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.5005\/jp-journals-10071-24231","volume":"26","author":"P Sahoo","year":"2022","unstructured":"Sahoo P, Kothari N, Goyal S, Sharma A, Bhatia PK. Comparison of norepinephrine and terlipressin vs norepinephrine alone for management of septic shock: a randomized control study. Indian J Crit Care Med. 2022;26(6):669\u201375. https:\/\/doi.org\/10.5005\/jp-journals-10071-24231.","journal-title":"Indian J Crit Care Med"},{"key":"5669_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13054-023-04322-y","volume":"27","author":"Y Kotani","year":"2023","unstructured":"Kotani Y, Di Gioia A, Landoni G, et al. An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity. Crit Care. 2023;27:29. https:\/\/doi.org\/10.1186\/s13054-023-04322-y.","journal-title":"Crit Care"},{"issue":"1\u20132","key":"5669_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/milmed\/usae369","volume":"190","author":"W Li","year":"2025","unstructured":"Li W, Deng J. Effect of continuous infusion therapy with low-dose terlipressin combined with norepinephrine on hemodynamics, inflammatory markers, and prognosis in patients with severe septic shock. Mil Med. 2025;190(1\u20132):116\u201323. https:\/\/doi.org\/10.1093\/milmed\/usae369.","journal-title":"Mil Med"},{"issue":"4","key":"5669_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/SHK.0000000000002204","volume":"60","author":"F Mao","year":"2023","unstructured":"Mao F, Liang D, Tang Z, Xu Y, Lin L. Terlipressin combined with norepinephrine in the treatment of septic shock: a systematic review. Shock. 2023;60(4):479\u201386. https:\/\/doi.org\/10.1097\/SHK.0000000000002204.","journal-title":"Shock"},{"issue":"1","key":"5669_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-020-00965-4","volume":"20","author":"L Huang","year":"2020","unstructured":"Huang L, Zhang S, Chang W, Xia F, Liu S, Yang Y, et al. Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis. BMC Anesthesiol. 2020;20(1):58. https:\/\/doi.org\/10.1186\/s12871-020-00965-4.","journal-title":"BMC Anesthesiol"},{"key":"5669_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-019-0369-1","volume":"7","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Huang H, Xi X, Du B. Terlipressin for septic shock patients: a meta-analysis of randomized controlled study. J Intensive Care. 2019;7:16.","journal-title":"J Intensive Care"},{"issue":"1","key":"5669_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05212-7","volume":"28","author":"Y Kotani","year":"2024","unstructured":"Kotani Y, Belletti A, D\u2019Amico F, Bonaccorso A, Wieruszewski PM, Fujii T, et al. Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials. Crit Care. 2024;28(1):439. https:\/\/doi.org\/10.1186\/s13054-024-05212-7.","journal-title":"Crit Care"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05669-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05669-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05669-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:05:53Z","timestamp":1761041153000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05669-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5669"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05669-0","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Siriraj Institutional Review Board approved the study protocol (reference: Si\u202f049\/2020). Written informed consent was obtained from each patient or from next of kin or legal guardians when the patient was unable to consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"443"}}